# Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas

> **NCT01380028** · PHASE3 · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 162 (actual)

## Conditions studied

- Chronic Intracranial Subdural Hematoma

## Interventions

- **DRUG:** oral corticosteroids
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01380028
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07-22
- **Primary completion:** 2014-09-12
- **Final completion:** 2014-09-12
- **Target enrollment:** 162 (ACTUAL)
- **Why stopped:** successfull Interim Analysis
- **Last updated:** 2021-12-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380028, "Interest of Oral Corticosteroids in the Treatment of Chronic Subdural Hematomas". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01380028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*